Zydus Cadilas US subsidiary Zydus Pharmaceuticals USA Inc has received tentative approval from the USFDA to market Pimavanserin Capsules in the strength of 34 mg USRLD Nuplazid Capsules Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis The drug will be manufactured at the groups formulation manufacturing facility at SEZ Ahmedabad The group now […]
Graphite India announced that ICRA has on enhanced credit limit of Rs 1400 crore Rs 1000 crore earlier for working capital facilities of the Company reaffirmed the long term rating at [ICRA] AA pronounced ICRA double A plus and short term rating at [ICRA] A1 pronounced ICRA A one plus The outlook on the long-term rating has also been retained as Stable
Tech Mahindra approved the proposal to acquire 100Percentage equity shares in Allyis India and the Companys wholly owned subsidiary viz Tech Mahindra Americas Inc approved the proposal to acquire 100Percentage equity shares in Green Investments LLC holding company for Allyis Group together called as Target The acquisition will bolster Tech Mahindras capabilities in Digital Experience Solutions Learning Development Marketing Instructional Design; Engineering Cloud Automation BI […]
Arex Industries will hold a meeting of the Board of Directors of the Company on 7 January 2022
Oil Natural Gas Corpn announced the appointment of Dr Prabhakar DIN 09453169 has been appointment as Non-official Independent Director on the Board of the Company wef 31 December 2021
Cipla will hold a meeting of the Board of Directors of the Company on 25 January 2022
Siemens Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 22-Jan-2022 to 04-Feb-2022 for the purpose of Dividend.
Union Bank of India has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jay Bharat Maruti Limited has informed the Exchange about Loss of Share Certificates under Regulation 39(3) of SEBI LODR, 2015
Affle (India) Limited has informed the Exchange about Schedule of meet and Scheduled meet on Jan 6, 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.